ArticleJournal of the American Association for Laboratory Animal Science : JAALAS2025
Effects of Long-Term Carprofen and Omeprazole Administration in C57BL/6J Mice.
Article in Journal of the American Association for Laboratory Animal Science : JAALAS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Osteoarthritis is the leading cause of disability in the United States and affects approximately half of adults over the age of 65. Many osteoarthritis patients take nonsteroidal anti-inflammatory drugs (NSAIDs) on a long-term basis, often concurrently with proton pump inhibitors (PPIs), such as omeprazole, to prevent gastric ulceration. Mice (Mus musculus) are a commonly used animal model of osteoarthritis. There are little data regarding long-term administration of NSAIDs or coadministration of PPIs and NSAIDs in mice. This study sought to determine if administration of carprofen, a commonly used veterinary NSAID, has adverse effects when administered for 21 days and if coadministration of omeprazole reduces the incidence of adverse effects. Four groups of C57BL/6J male (n = 5/group) and female (n = 5/group) mice were weighed daily and administered 10 mg/kg carprofen and 8.2 mg/kg omeprazole, 10 mg/kg carprofen, 8.2 mg/kg omeprazole, or control suspension once daily by oral gavage for 21 days. All mice were euthanized, and complete blood count (CBC), serum chemistry, fecal occult blood, and pyloric histopathology and gastritis scoring were conducted. All animals remained clinically healthy for the duration of the study. White blood cell counts (WBCs) and platelets were significantly lower in the carprofen and omeprazole group. Neutrophil counts were significantly lower in the carprofen and omeprazole and the carprofen groups. Compared with the control group, albumin was significantly higher in the carprofen group. Fecal occult blood tests were negative for all animals. No animals had pyloric mucosal ulceration, and gastritis scores were not significantly different between groups. Body weight significantly decreased for all groups over time, with no significant differences among treatment groups. Carprofen and omeprazole may be safely administered to C57BL/6J mice for 21 days but may induce significant changes in CBC and serum chemistry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.